The global Contraceptive Drugs market was valued at 1016.33 Million USD in 2020 and will grow with a CAGR of 3.85% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Contraceptive Drugs are medications that prevent pregnancy. They are one method of birth controlBirth controls are been used since ancient times but the safe and effective methods are introduce and available from 20th century. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg.
By Market Verdors:
Merck
Pfizer
Teva Pharmaceutical
Bayer
Allergan
Janssen
Mankind Pharma
Piramal Enterprises
Reckitt Benckiser
Church & Dwight
By Types:
Oral Contraceptives
Injectable
By Applications:
Hospitals
Clinics
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Contraceptive Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global Contraceptive Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Contraceptive Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Contraceptive Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Contraceptive Drugs Industry Impact
Chapter 2 Global Contraceptive Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Contraceptive Drugs (Volume and Value) by Type
2.1.1 Global Contraceptive Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global Contraceptive Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global Contraceptive Drugs (Volume and Value) by Application
2.2.1 Global Contraceptive Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global Contraceptive Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global Contraceptive Drugs (Volume and Value) by Regions
2.3.1 Global Contraceptive Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Contraceptive Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Contraceptive Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Contraceptive Drugs Consumption by Regions (2016-2021)
4.2 North America Contraceptive Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Contraceptive Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Contraceptive Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Contraceptive Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Contraceptive Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Contraceptive Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Contraceptive Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Contraceptive Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America Contraceptive Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Contraceptive Drugs Market Analysis
5.1 North America Contraceptive Drugs Consumption and Value Analysis
5.1.1 North America Contraceptive Drugs Market Under COVID-19
5.2 North America Contraceptive Drugs Consumption Volume by Types
5.3 North America Contraceptive Drugs Consumption Structure by Application
5.4 North America Contraceptive Drugs Consumption by Top Countries
5.4.1 United States Contraceptive Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada Contraceptive Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico Contraceptive Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia Contraceptive Drugs Market Analysis
6.1 East Asia Contraceptive Drugs Consumption and Value Analysis
6.1.1 East Asia Contraceptive Drugs Market Under COVID-19
6.2 East Asia Contraceptive Drugs Consumption Volume by Types
6.3 East Asia Contraceptive Drugs Consumption Structure by Application
6.4 East Asia Contraceptive Drugs Consumption by Top Countries
6.4.1 China Contraceptive Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan Contraceptive Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea Contraceptive Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe Contraceptive Drugs Market Analysis
7.1 Europe Contraceptive Drugs Consumption and Value Analysis
7.1.1 Europe Contraceptive Drugs Market Under COVID-19
7.2 Europe Contraceptive Drugs Consumption Volume by Types
7.3 Europe Contraceptive Drugs Consumption Structure by Application
7.4 Europe Contraceptive Drugs Consumption by Top Countries
7.4.1 Germany Contraceptive Drugs Consumption Volume from 2016 to 2021
7.4.2 UK Contraceptive Drugs Consumption Volume from 2016 to 2021
7.4.3 France Contraceptive Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy Contraceptive Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia Contraceptive Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain Contraceptive Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands Contraceptive Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland Contraceptive Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland Contraceptive Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia Contraceptive Drugs Market Analysis
8.1 South Asia Contraceptive Drugs Consumption and Value Analysis
8.1.1 South Asia Contraceptive Drugs Market Under COVID-19
8.2 South Asia Contraceptive Drugs Consumption Volume by Types
8.3 South Asia Contraceptive Drugs Consumption Structure by Application
8.4 South Asia Contraceptive Drugs Consumption by Top Countries
8.4.1 India Contraceptive Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan Contraceptive Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Contraceptive Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Contraceptive Drugs Market Analysis
9.1 Southeast Asia Contraceptive Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Contraceptive Drugs Market Under COVID-19
9.2 Southeast Asia Contraceptive Drugs Consumption Volume by Types
9.3 Southeast Asia Contraceptive Drugs Consumption Structure by Application
9.4 Southeast Asia Contraceptive Drugs Consumption by Top Countries
9.4.1 Indonesia Contraceptive Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand Contraceptive Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore Contraceptive Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia Contraceptive Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines Contraceptive Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam Contraceptive Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar Contraceptive Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East Contraceptive Drugs Market Analysis
10.1 Middle East Contraceptive Drugs Consumption and Value Analysis
10.1.1 Middle East Contraceptive Drugs Market Under COVID-19
10.2 Middle East Contraceptive Drugs Consumption Volume by Types
10.3 Middle East Contraceptive Drugs Consumption Structure by Application
10.4 Middle East Contraceptive Drugs Consumption by Top Countries
10.4.1 Turkey Contraceptive Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Contraceptive Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran Contraceptive Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Contraceptive Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel Contraceptive Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq Contraceptive Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar Contraceptive Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait Contraceptive Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman Contraceptive Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa Contraceptive Drugs Market Analysis
11.1 Africa Contraceptive Drugs Consumption and Value Analysis
11.1.1 Africa Contraceptive Drugs Market Under COVID-19
11.2 Africa Contraceptive Drugs Consumption Volume by Types
11.3 Africa Contraceptive Drugs Consumption Structure by Application
11.4 Africa Contraceptive Drugs Consumption by Top Countries
11.4.1 Nigeria Contraceptive Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa Contraceptive Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt Contraceptive Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria Contraceptive Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco Contraceptive Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania Contraceptive Drugs Market Analysis
12.1 Oceania Contraceptive Drugs Consumption and Value Analysis
12.2 Oceania Contraceptive Drugs Consumption Volume by Types
12.3 Oceania Contraceptive Drugs Consumption Structure by Application
12.4 Oceania Contraceptive Drugs Consumption by Top Countries
12.4.1 Australia Contraceptive Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand Contraceptive Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America Contraceptive Drugs Market Analysis
13.1 South America Contraceptive Drugs Consumption and Value Analysis
13.1.1 South America Contraceptive Drugs Market Under COVID-19
13.2 South America Contraceptive Drugs Consumption Volume by Types
13.3 South America Contraceptive Drugs Consumption Structure by Application
13.4 South America Contraceptive Drugs Consumption Volume by Major Countries
13.4.1 Brazil Contraceptive Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina Contraceptive Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia Contraceptive Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile Contraceptive Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela Contraceptive Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru Contraceptive Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Contraceptive Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador Contraceptive Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Contraceptive Drugs Business
14.1 Merck
14.1.1 Merck Company Profile
14.1.2 Merck Contraceptive Drugs Product Specification
14.1.3 Merck Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Pfizer
14.2.1 Pfizer Company Profile
14.2.2 Pfizer Contraceptive Drugs Product Specification
14.2.3 Pfizer Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Teva Pharmaceutical
14.3.1 Teva Pharmaceutical Company Profile
14.3.2 Teva Pharmaceutical Contraceptive Drugs Product Specification
14.3.3 Teva Pharmaceutical Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Bayer
14.4.1 Bayer Company Profile
14.4.2 Bayer Contraceptive Drugs Product Specification
14.4.3 Bayer Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Allergan
14.5.1 Allergan Company Profile
14.5.2 Allergan Contraceptive Drugs Product Specification
14.5.3 Allergan Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Janssen
14.6.1 Janssen Company Profile
14.6.2 Janssen Contraceptive Drugs Product Specification
14.6.3 Janssen Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Mankind Pharma
14.7.1 Mankind Pharma Company Profile
14.7.2 Mankind Pharma Contraceptive Drugs Product Specification
14.7.3 Mankind Pharma Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Piramal Enterprises
14.8.1 Piramal Enterprises Company Profile
14.8.2 Piramal Enterprises Contraceptive Drugs Product Specification
14.8.3 Piramal Enterprises Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Reckitt Benckiser
14.9.1 Reckitt Benckiser Company Profile
14.9.2 Reckitt Benckiser Contraceptive Drugs Product Specification
14.9.3 Reckitt Benckiser Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Church & Dwight
14.10.1 Church & Dwight Company Profile
14.10.2 Church & Dwight Contraceptive Drugs Product Specification
14.10.3 Church & Dwight Contraceptive Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Contraceptive Drugs Market Forecast (2022-2027)
15.1 Global Contraceptive Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Contraceptive Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Contraceptive Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global Contraceptive Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Contraceptive Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Contraceptive Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Contraceptive Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Contraceptive Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Contraceptive Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Contraceptive Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Contraceptive Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Contraceptive Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Contraceptive Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Contraceptive Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Contraceptive Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Contraceptive Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Contraceptive Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global Contraceptive Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global Contraceptive Drugs Price Forecast by Type (2022-2027)
15.4 Global Contraceptive Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 Contraceptive Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...
Overview of the Global Sex Hormone Drugs Market:
The report discusses everything a marketer requires before investing in the global Sex Hormone Drugs Market during the forecast period 2023-2030. It provides detailed...
Executive Summary
Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...
Overview of the Global Microecological Drugs Market :
The report discusses everything a marketer requires before investing in the global Microecological Drugs Market during the forecast period 2023-2030. It provide...
Overview of the Global Biosynthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Biosynthesis Peptide Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Chemical Synthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Chemical Synthesis Peptide Drugs Market during the forecast period 2...
Description
The global veterinary dermatology drugs market exhibits positive growth prospects, forecast to expand at a CAGR of 5.4% between 2023 and 2029 to reach USD 8.08 billion in value. Veterinary dermatology focuses on treating skin diseases and disorders in animal patients, covering both...
Overview of the Global Drug Rehabilitation Drugs Market :
The report discusses everything a marketer requires before investing in the global Drug Rehabilitation Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Rosuvastatin Drugs Market:
The report discusses everything a marketer requires before investing in the global Rosuvastatin Drugs Market during the forecast period 2023-2030. It provides detail...